CN106282104A - 从脐带组织中高效获取间充质干细胞的方法 - Google Patents
从脐带组织中高效获取间充质干细胞的方法 Download PDFInfo
- Publication number
- CN106282104A CN106282104A CN201610605997.2A CN201610605997A CN106282104A CN 106282104 A CN106282104 A CN 106282104A CN 201610605997 A CN201610605997 A CN 201610605997A CN 106282104 A CN106282104 A CN 106282104A
- Authority
- CN
- China
- Prior art keywords
- cell
- umbilical cord
- tissue
- dpbs
- culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000003954 umbilical cord Anatomy 0.000 title claims abstract description 90
- 238000000034 method Methods 0.000 title claims abstract description 51
- 210000000130 stem cell Anatomy 0.000 title claims abstract description 34
- 210000004027 cell Anatomy 0.000 claims abstract description 97
- 230000029087 digestion Effects 0.000 claims abstract description 44
- 239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 claims abstract description 36
- 210000002249 digestive system Anatomy 0.000 claims abstract description 34
- 239000012531 culture fluid Substances 0.000 claims abstract description 26
- 239000000243 solution Substances 0.000 claims abstract description 25
- OZFAFGSSMRRTDW-UHFFFAOYSA-N (2,4-dichlorophenyl) benzenesulfonate Chemical compound ClC1=CC(Cl)=CC=C1OS(=O)(=O)C1=CC=CC=C1 OZFAFGSSMRRTDW-UHFFFAOYSA-N 0.000 claims abstract description 24
- 230000003321 amplification Effects 0.000 claims abstract description 24
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 24
- 102000004142 Trypsin Human genes 0.000 claims abstract description 15
- 108090000631 Trypsin Proteins 0.000 claims abstract description 15
- YRQNKMKHABXEJZ-UVQQGXFZSA-N chembl176323 Chemical compound C1C[C@]2(C)[C@@]3(C)CC(N=C4C[C@]5(C)CCC6[C@]7(C)CC[C@@H]([C@]7(CC[C@]6(C)[C@@]5(C)CC4=N4)C)CCCCCCCC)=C4C[C@]3(C)CCC2[C@]2(C)CC[C@H](CCCCCCCC)[C@]21C YRQNKMKHABXEJZ-UVQQGXFZSA-N 0.000 claims abstract description 14
- 238000004140 cleaning Methods 0.000 claims abstract description 14
- 239000012588 trypsin Substances 0.000 claims abstract description 13
- 238000000926 separation method Methods 0.000 claims abstract description 12
- 239000000706 filtrate Substances 0.000 claims abstract description 11
- 239000012679 serum free medium Substances 0.000 claims abstract description 11
- 238000005119 centrifugation Methods 0.000 claims abstract description 10
- 238000009288 screen filtration Methods 0.000 claims abstract description 9
- 210000004271 bone marrow stromal cell Anatomy 0.000 claims description 61
- 230000009977 dual effect Effects 0.000 claims description 32
- 238000001556 precipitation Methods 0.000 claims description 17
- 210000000038 chest Anatomy 0.000 claims description 11
- 230000001464 adherent effect Effects 0.000 claims description 9
- 239000012634 fragment Substances 0.000 claims description 9
- 230000001079 digestive effect Effects 0.000 claims description 8
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 8
- 230000008859 change Effects 0.000 claims description 7
- 239000002609 medium Substances 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 239000002244 precipitate Substances 0.000 claims description 7
- 210000004204 blood vessel Anatomy 0.000 claims description 6
- 239000004744 fabric Substances 0.000 claims description 6
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 claims description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 5
- 239000012930 cell culture fluid Substances 0.000 claims description 5
- 230000036541 health Effects 0.000 claims description 5
- 239000006228 supernatant Substances 0.000 claims description 5
- 229930182555 Penicillin Natural products 0.000 claims description 3
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims description 3
- 239000001963 growth medium Substances 0.000 claims description 3
- 235000015097 nutrients Nutrition 0.000 claims description 3
- 229940049954 penicillin Drugs 0.000 claims description 3
- 229960005322 streptomycin Drugs 0.000 claims description 3
- 238000004062 sedimentation Methods 0.000 claims description 2
- 238000002386 leaching Methods 0.000 claims 1
- 238000004321 preservation Methods 0.000 claims 1
- 238000005406 washing Methods 0.000 claims 1
- 230000004069 differentiation Effects 0.000 abstract description 11
- 210000002901 mesenchymal stem cell Anatomy 0.000 abstract description 4
- 238000001914 filtration Methods 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 description 59
- 238000005457 optimization Methods 0.000 description 9
- 230000006698 induction Effects 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 229940088598 enzyme Drugs 0.000 description 6
- 210000001185 bone marrow Anatomy 0.000 description 5
- 230000032258 transport Effects 0.000 description 4
- 230000002293 adipogenic effect Effects 0.000 description 3
- RGCKGOZRHPZPFP-UHFFFAOYSA-N alizarin Chemical compound C1=CC=C2C(=O)C3=C(O)C(O)=CC=C3C(=O)C2=C1 RGCKGOZRHPZPFP-UHFFFAOYSA-N 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000001976 enzyme digestion Methods 0.000 description 3
- 238000000684 flow cytometry Methods 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 230000002188 osteogenic effect Effects 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 2
- 210000001789 adipocyte Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 230000005847 immunogenicity Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 230000009897 systematic effect Effects 0.000 description 2
- 210000001113 umbilicus Anatomy 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- 102100022464 5'-nucleotidase Human genes 0.000 description 1
- 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 description 1
- 102100032912 CD44 antigen Human genes 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 102100037241 Endoglin Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 102000006354 HLA-DR Antigens Human genes 0.000 description 1
- 108010058597 HLA-DR Antigens Proteins 0.000 description 1
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 1
- 101000678236 Homo sapiens 5'-nucleotidase Proteins 0.000 description 1
- 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 description 1
- 101000868273 Homo sapiens CD44 antigen Proteins 0.000 description 1
- 101000881679 Homo sapiens Endoglin Proteins 0.000 description 1
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 1
- 101001046686 Homo sapiens Integrin alpha-M Proteins 0.000 description 1
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 1
- 101000800116 Homo sapiens Thy-1 membrane glycoprotein Proteins 0.000 description 1
- 102100022338 Integrin alpha-M Human genes 0.000 description 1
- 241000736199 Paeonia Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 1
- 102100033523 Thy-1 membrane glycoprotein Human genes 0.000 description 1
- 238000006123 Wharton fragmentation reaction Methods 0.000 description 1
- 238000004115 adherent culture Methods 0.000 description 1
- 210000004504 adult stem cell Anatomy 0.000 description 1
- 210000001691 amnion Anatomy 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000002458 cell surface marker Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000002468 fat body Anatomy 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 210000003701 histiocyte Anatomy 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 210000003716 mesoderm Anatomy 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000004409 osteocyte Anatomy 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0668—Mesenchymal stem cells from other natural sources
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Developmental Biology & Embryology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Rheumatology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610605997.2A CN106282104A (zh) | 2016-07-29 | 2016-07-29 | 从脐带组织中高效获取间充质干细胞的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610605997.2A CN106282104A (zh) | 2016-07-29 | 2016-07-29 | 从脐带组织中高效获取间充质干细胞的方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106282104A true CN106282104A (zh) | 2017-01-04 |
Family
ID=57662755
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610605997.2A Pending CN106282104A (zh) | 2016-07-29 | 2016-07-29 | 从脐带组织中高效获取间充质干细胞的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106282104A (zh) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107164319A (zh) * | 2017-05-25 | 2017-09-15 | 佛山科学技术学院 | 一种原代培养犬脐带来源的间充质干细胞的方法 |
CN108165526A (zh) * | 2017-12-20 | 2018-06-15 | 北京焕生汇生物技术研究院 | 酶解法提取及培养人脐带间充质干细胞的方法 |
CN108660108A (zh) * | 2017-03-31 | 2018-10-16 | 四川新生命干细胞科技股份有限公司 | 一种可增强脐带间充质干细胞免疫调节能力的方法 |
CN109666627A (zh) * | 2019-02-15 | 2019-04-23 | 温州医科大学附属第二医院、温州医科大学附属育英儿童医院 | 小分子诱导脐带间充质干细胞分化为睾丸间质细胞的方法 |
CN109825469A (zh) * | 2019-03-09 | 2019-05-31 | 和携科技(北京)有限公司 | 一种促进人源脐带间充质干细胞向软骨细胞分化的诱导方法 |
CN109876010A (zh) * | 2019-03-09 | 2019-06-14 | 和携科技(北京)有限公司 | 一种用于治疗烧烫伤术后修复皮下组织的人脐带间充质干细胞分泌因子注射液的制备方法 |
CN109929800A (zh) * | 2019-03-09 | 2019-06-25 | 和携科技(北京)有限公司 | 一种干细胞分泌因子的获取与纯化方法 |
CN110257327A (zh) * | 2019-06-27 | 2019-09-20 | 重庆市细胞生物工程技术有限公司 | 一种脐带间充质干细胞的分离培养方法 |
CN110964693A (zh) * | 2019-12-27 | 2020-04-07 | 河北银丰鼎诚生物技术有限公司 | 一种脐带间充质干细胞的分离方法 |
CN111117954A (zh) * | 2020-01-18 | 2020-05-08 | 北京永华燕芸生物科技有限公司 | 一种脐带来源原代间充质干细胞的分离培养方法 |
CN111826343A (zh) * | 2020-07-23 | 2020-10-27 | 北京中卫医正科技有限公司 | 一种增强诱导软骨分化的细胞培养液、方法及应用 |
CN113322231A (zh) * | 2021-06-23 | 2021-08-31 | 陕西九州生物医药科技集团有限公司 | 一种间充质干细胞的分离和培养方法及制剂 |
CN114854679A (zh) * | 2022-04-20 | 2022-08-05 | 四川大学华西医院 | 脐带间充质干细胞扩增培养的方法 |
CN115044545A (zh) * | 2022-07-11 | 2022-09-13 | 睿博斯(北京)生物科技有限公司 | 一种间充质干细胞及其制备方法 |
CN115948331A (zh) * | 2022-10-17 | 2023-04-11 | 中国人民解放军西部战区总医院 | 一种从小鼠胆囊中分离获取间充质干细胞的方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102010850A (zh) * | 2009-12-15 | 2011-04-13 | 和泽生物科技有限公司 | 一种脐带组织间充质干细胞爬片分离的方法 |
CN103396990A (zh) * | 2013-08-22 | 2013-11-20 | 顺昊细胞生物技术(天津)有限公司 | 一种制备间充质干细胞的方法 |
CN104450611A (zh) * | 2014-11-28 | 2015-03-25 | 广州赛莱拉干细胞科技股份有限公司 | 一种人羊膜间充质干细胞原代分离及培养方法 |
-
2016
- 2016-07-29 CN CN201610605997.2A patent/CN106282104A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102010850A (zh) * | 2009-12-15 | 2011-04-13 | 和泽生物科技有限公司 | 一种脐带组织间充质干细胞爬片分离的方法 |
CN103396990A (zh) * | 2013-08-22 | 2013-11-20 | 顺昊细胞生物技术(天津)有限公司 | 一种制备间充质干细胞的方法 |
CN104450611A (zh) * | 2014-11-28 | 2015-03-25 | 广州赛莱拉干细胞科技股份有限公司 | 一种人羊膜间充质干细胞原代分离及培养方法 |
Non-Patent Citations (2)
Title |
---|
周琪主编: "《生物学实验指南丛书 干细胞实验指南[M]》", 31 July 2015, 北京:中央广播电视大学出版社 * |
秦鸿雁,郑敏化编: "《遗传修饰小鼠实用实验技术[M].》", 31 July 2012 * |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108660108A (zh) * | 2017-03-31 | 2018-10-16 | 四川新生命干细胞科技股份有限公司 | 一种可增强脐带间充质干细胞免疫调节能力的方法 |
CN107164319B (zh) * | 2017-05-25 | 2021-06-01 | 佛山科学技术学院 | 一种原代培养犬脐带来源的间充质干细胞的方法 |
CN107164319A (zh) * | 2017-05-25 | 2017-09-15 | 佛山科学技术学院 | 一种原代培养犬脐带来源的间充质干细胞的方法 |
CN108165526A (zh) * | 2017-12-20 | 2018-06-15 | 北京焕生汇生物技术研究院 | 酶解法提取及培养人脐带间充质干细胞的方法 |
CN109666627A (zh) * | 2019-02-15 | 2019-04-23 | 温州医科大学附属第二医院、温州医科大学附属育英儿童医院 | 小分子诱导脐带间充质干细胞分化为睾丸间质细胞的方法 |
CN109825469A (zh) * | 2019-03-09 | 2019-05-31 | 和携科技(北京)有限公司 | 一种促进人源脐带间充质干细胞向软骨细胞分化的诱导方法 |
CN109876010A (zh) * | 2019-03-09 | 2019-06-14 | 和携科技(北京)有限公司 | 一种用于治疗烧烫伤术后修复皮下组织的人脐带间充质干细胞分泌因子注射液的制备方法 |
CN109929800A (zh) * | 2019-03-09 | 2019-06-25 | 和携科技(北京)有限公司 | 一种干细胞分泌因子的获取与纯化方法 |
CN110257327A (zh) * | 2019-06-27 | 2019-09-20 | 重庆市细胞生物工程技术有限公司 | 一种脐带间充质干细胞的分离培养方法 |
CN110964693A (zh) * | 2019-12-27 | 2020-04-07 | 河北银丰鼎诚生物技术有限公司 | 一种脐带间充质干细胞的分离方法 |
CN111117954A (zh) * | 2020-01-18 | 2020-05-08 | 北京永华燕芸生物科技有限公司 | 一种脐带来源原代间充质干细胞的分离培养方法 |
CN111826343A (zh) * | 2020-07-23 | 2020-10-27 | 北京中卫医正科技有限公司 | 一种增强诱导软骨分化的细胞培养液、方法及应用 |
CN113322231A (zh) * | 2021-06-23 | 2021-08-31 | 陕西九州生物医药科技集团有限公司 | 一种间充质干细胞的分离和培养方法及制剂 |
CN114854679A (zh) * | 2022-04-20 | 2022-08-05 | 四川大学华西医院 | 脐带间充质干细胞扩增培养的方法 |
CN115044545A (zh) * | 2022-07-11 | 2022-09-13 | 睿博斯(北京)生物科技有限公司 | 一种间充质干细胞及其制备方法 |
CN115948331A (zh) * | 2022-10-17 | 2023-04-11 | 中国人民解放军西部战区总医院 | 一种从小鼠胆囊中分离获取间充质干细胞的方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106282104A (zh) | 从脐带组织中高效获取间充质干细胞的方法 | |
CN102676452B (zh) | 一种含人脐带间充质干细胞分泌液的培养基及其制备方法和应用 | |
CN106754674B (zh) | 从人胎盘羊膜制备羊膜间充质干细胞的方法及其应用 | |
CN102807966B (zh) | 胎盘全细胞冻存、复苏以及分离和扩增干细胞的方法 | |
CN105238751B (zh) | 一种脐带组织间充质干细胞的分离培养方法 | |
CN104357387B (zh) | 一种从人脂肪组织中分离人脂肪干细胞的方法 | |
CN109234229B (zh) | 从胎盘血管分离间充质干细胞的方法和所用消化酶组合物 | |
CN106635968A (zh) | 人脐带源间充质干细胞诱导分化成软骨细胞的方法 | |
CN107475190B (zh) | 一种脂肪svf细胞临床级高效制备和冻存的方法及其用途 | |
CN102367435B (zh) | 人富血小板血浆的制备及在人间充质干细胞分离培养中的应用 | |
CN104762257B (zh) | 一种从脐带制备间充质干细胞的方法 | |
CN107022521A (zh) | 壁蜕膜组织冻存、复苏及分离培养间充质干细胞的方法 | |
CN104498433A (zh) | 一种脂肪干细胞的提取方法以及制剂和应用 | |
CN103013911A (zh) | 贴壁密度梯度法联合egf培养人脐带间充质干细胞的方法 | |
CN104450611A (zh) | 一种人羊膜间充质干细胞原代分离及培养方法 | |
CN102433299A (zh) | 小鼠脂肪干细胞的分离、培养及纯化方法 | |
CN102154200B (zh) | 临床治疗用脐带间充质干细胞的制备和保存 | |
CN102851255A (zh) | 一种高效快速分离人间充质干细胞的方法 | |
CN105434468A (zh) | 一种皮肤细胞损伤修复试剂的制备方法 | |
CN103421739A (zh) | 一种高效分离脐带间充质干细胞的方法 | |
CN105505865A (zh) | 一种脐带间充质干细胞的分离方法 | |
CN109628388B (zh) | 用消化酶组合物从胎盘血管分离间充质干细胞 | |
CN102191229A (zh) | 一种快速有效获得脐带间充质干细胞(msc)的方法 | |
CN106417253A (zh) | 一种骨骼肌干细胞的冻存液和冻存方法 | |
Ferroni et al. | Methods to isolate adipose tissue-derived stem cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20170606 Address after: 101111 Beijing branch of Daxing District economic and Technological Development Zone Street No. 88 Yizhuang biomedical park E1-501 Applicant after: Defender Huayi (Beijing) Biotechnology Co. Ltd. Applicant after: Huayue will (Beijing) Medical Technology Co Ltd Address before: 101111 Beijing branch of Daxing District economic and Technological Development Zone Street No. 88 Yizhuang biomedical park E1-501 Applicant before: Defender Huayi (Beijing) Biotechnology Co. Ltd. |
|
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170104 |